The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
17
SAH derived potent and selective EZH2 inhibitors.EBI
Pfizer
25
Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.EBI
University of North Carolina at Chapel Hill
47
Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors.EBI
University of North Carolina at Chapel Hill
6
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.EBI
TBA
21
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.EBI
University of North Carolina at Chapel Hill
11
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.EBI
UNC Eshelman School of Pharmacy
2
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor.EBI
Daiichi Sankyo Co., Ltd
15
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.EBI
University College London
29
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitorsBDB
Incyte
8
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBDB
Merck Sharpe & Dohme